224 related articles for article (PubMed ID: 18982740)
1. Characteristics of hepatitis C infection in injecting drug users in Zadar County, Croatia.
Medić A; Dzelalija B; Sonicki Z; Zekanović D
Coll Antropol; 2008 Sep; 32(3):697-702. PubMed ID: 18982740
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of hepatitis B, hepatitis C and HIV among injecting drug users treated outpatiently and in therapeutic community in Brod-Posavina County, Croatia].
Kolovrat A; Jurisić I; Marić Z; Cvitković A
Acta Med Croatica; 2010 Oct; 64(4):287-96. PubMed ID: 21688612
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C prevalence and risk behavior of injecting drug users in Sydney: a continuing concern.
Habib SE; Lovejoy FH; Aspin C
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):823-34. PubMed ID: 12041560
[TBL] [Abstract][Full Text] [Related]
4. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
5. [Risk factors for hepatitis C among injecting drug users in Oslo].
Dalgard O; Egeland A; Ervik R; Vilimas K; Skaug K; Steen TW
Tidsskr Nor Laegeforen; 2009 Jan; 129(2):101-4. PubMed ID: 19151801
[TBL] [Abstract][Full Text] [Related]
6. Irish injecting drug users and hepatitis C: the importance of the social context of injecting.
Smyth BP; Barry J; Keenan E
Int J Epidemiol; 2005 Feb; 34(1):166-72. PubMed ID: 15513970
[TBL] [Abstract][Full Text] [Related]
7. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
Kemp R; Miller J; Lungley S; Baker M
N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C prevalence and needle/syringe sharing behaviours in recent onset injecting drug users.
Robinson GM; Reynolds JN; Robinson BJ
N Z Med J; 1995 Mar; 108(996):103-5. PubMed ID: 7715873
[TBL] [Abstract][Full Text] [Related]
9. Knowledge of status and assessment of personal health consequences with hepatitis C are not enough to change risk behaviour among injecting drug users in Stockholm County, Sweden.
Norden L; Saxon L; Kåberg M; Käll K; Franck J; Lidman C
Scand J Infect Dis; 2009; 41(10):727-34. PubMed ID: 19688640
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of HCV in a cohort of injectors on methadone substitution treatment.
Lee KC; Lim WW; Lee SS
J Clin Virol; 2008 Apr; 41(4):297-300. PubMed ID: 18191614
[TBL] [Abstract][Full Text] [Related]
11. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.
Miller CL; Johnston C; Spittal PM; Li K; Laliberté N; Montaner JS; Schechter MT
Hepatology; 2002 Sep; 36(3):737-42. PubMed ID: 12198668
[TBL] [Abstract][Full Text] [Related]
12. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
[TBL] [Abstract][Full Text] [Related]
13. Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users.
Burt RD; Thiede H; Hagan H
Drug Alcohol Depend; 2009 Dec; 105(3):215-20. PubMed ID: 19720473
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy.
Quaglio G; Lugoboni F; Pajusco B; Sarti M; Talamini G; Lechi A; Mezzelani P; Des Jarlais DC
Clin Infect Dis; 2003 Jul; 37(1):33-40. PubMed ID: 12830406
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination?
Day C; Ross J; Dolan K
Drug Alcohol Rev; 2003 Sep; 22(3):317-21. PubMed ID: 15385226
[TBL] [Abstract][Full Text] [Related]
17. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities.
Thiede H; Hagan H; Campbell JV; Strathdee SA; Bailey SL; Hudson SM; Kapadia F; Garfein RS;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S39-47. PubMed ID: 17466464
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
Oliveira Mde L; Bastos FI; Telles PR; Hacker Mde A; Oliveira SA; Miguel JC; Yoshida CF
J Clin Virol; 2009 Mar; 44(3):200-6. PubMed ID: 19195927
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience.
Roy E; Boudreau JF; Boivin JF
Drug Alcohol Depend; 2009 Jun; 102(1-3):158-61. PubMed ID: 19251382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]